ONCLIVE NEWS NETWORK: ON LOCATION WILL BE LIVE AT ESMO THIS WEEK - STAY TUNED FOR MORE INFORMATION!

Dr. Attai Discusses 5-Year Outcomes for APBI With Strut-Based Brachytherapy

Deanna J. Attai, MD
Published: Wednesday, Sep 17, 2014

Deanna J. Attai, MD, assistant clinical professor, Department of Surgery, UCLA, discusses a 5-year follow up of patients receiving accelerated partial breast irradiation (APBI) using strut-based applicators.

In this trial, patients were treated with APBI and followed over time. After a median follow up of 5 years, data showed that local recurrence rates and cosmetic outcomes were excellent. Results were comparable to other studies of partial breast irradiation.

This 5-year data supports the use of partial breast irradiation, Attai says, especially with a strut-based applicator.

Deanna J. Attai, MD, assistant clinical professor, Department of Surgery, UCLA, discusses a 5-year follow up of patients receiving accelerated partial breast irradiation (APBI) using strut-based applicators.

In this trial, patients were treated with APBI and followed over time. After a median follow up of 5 years, data showed that local recurrence rates and cosmetic outcomes were excellent. Results were comparable to other studies of partial breast irradiation.

This 5-year data supports the use of partial breast irradiation, Attai says, especially with a strut-based applicator.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Community Practice Connections: Oncology Best Practice™ Targeting Cell Cycle Progression: The Latest Advances on CDK4/6 Inhibition in Metastatic Breast CancerOct 31, 20181.0
Publication Bottom Border
Border Publication
x